Clinical Study

Urine β-2-Microglobulin, Osteopontin, and Trefoil Factor 3 May Early Predict Acute Kidney Injury and Outcome after Cardiac Arrest

Table 2

Multivariate analyses of risk factors for acute kidney injury, mortality, and poor neurological outcome in resuscitated, comatose out-of-hospital cardiac arrest patients.

CovariatesLevelsAdjusted OR (95% CI) valueAuROC (95% CI) with biomarkerAuROC (95% CI) without biomarker value

Risk factors for acute kidney injury
Model I ()SOFA score, day 0≥/<103.59 (1.72 to 7.47)0.0010.729 (0.658 to 0.800)0.700 (0.630 to 0.770)0.036
S-Urea, day 0≥/<6.7 mmol/L2.71 (1.47 to 5.04)0.001
Admission U-β2M≥/<2769 ng/mL2.14 (1.16 to 3.96)0.015
Model II ()S-Urea, day 0≥/<6.7 mmol/L2.18 (1.05 to 4.53)0.0360.722 (0.636 to 0.807)0.699 (0.612 to 0.786)0.249
Weighta≥/<85 kg2.09 (1.00 to 4.38)0.050
B-BE≥/<−7.0 mmol/L2.49 (1.20 to 5.20)0.015
U-Osteopontin, day 3≥/<1683 ng/mL2.07 (1.00 to 4.29)0.050

Risk factors for mortality
Model III ()S-Urea, day 0≥/<6.7 mmol/L2.16 (1.11 to 4.20)0.023 0.797 (0.733 to 0.861)0.774 (0.709 to 0.839)0.195
Not initial VT/VFaNo/yes5.29 (2.58 to 10.87)<0.001
SOFA score, day 0≥/< 104.46 (2.00 to 9.96)<0.001
Admission U-β2M≥/< 2769 ng/mL2.65 (1.36 to 5.18)0.004
Model IV ()Not initial VT/VFaNo/yes3.65 (1.71 to 7.76)0.0010.760 (0.687 to 0.833)0.702 (0.627 to 0.7780.027
SOFA score, day 0≥/<103.31 (1.43 to 7.69)0.005
U-TTF3, day 3≥/<2910 ng/mL3.40 (1.66 to 6.95)0.001

Risk factors for poor neurological outcomes
Model V ()S-Urea, day 0≥/<6.7 mmol/L2.19 (1.11 to 4.32)0.0240.812 (0.750 to 0.874)0.802 (0.740 to 0.864)0.167
Not initial VT/VFaNo/yes5.62 (2.64 to 11.97)<0.001
B-BE≥/<−7.0 mmol/L2.40 (1.18 to 4.85)0.015
SOFA score, day 0≥/< 102.98 (1.34 to 6.66)0.008
Admission U-β2M≥/< 2769 ng/mL2.10 (1.04 to 4.21)0.038
Model VI ()Not initial VT/VFaNo/yes3.83 (1.78 to 8.24)0.0010.758 (0.685 to 0.832)0.715 (0.638 to 0.791)0.101
B-BE≥/<−7.0 mmol/L2.95 (1.46 to 5.97)0.003
U-TTF3, day 3≥/<2910 ng/mL3.15 (1.56 to 6.40)0.001

Data are from multivariate logistic regression analysis. OR: odds ratio; CI: confidence interval; AuROC: area under the curve in the receiver operating characteristics curve; n: number; SOFA: sequential organ failure assessment; β2M: β-2-microglobulin; S: serum; U: urine; B: whole blood; BE: base excess; VF/VT: ventricular fibrillation/ventricular tachycardia; TFF3: trefoil factor 3. values for the adjusted odds ratio. values from comparing the AuROC with and without biomarkers. aData from some patients are missing.